118 related articles for article (PubMed ID: 27255895)
21. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
22. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
Kai L; Levenson AS
Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
[TBL] [Abstract][Full Text] [Related]
23. AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.
Cao R; Ke M; Wu Q; Tian Q; Liu L; Dai Z; Lu S; Liu P
J Cell Physiol; 2019 Aug; 234(10):17444-17458. PubMed ID: 30820960
[TBL] [Abstract][Full Text] [Related]
24. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
25. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
26. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
27. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
[TBL] [Abstract][Full Text] [Related]
28. FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.
Zhou Y; Ou L; Xu J; Yuan H; Luo J; Shi B; Li X; Yang S; Wang Y
Cell Death Dis; 2021 Jul; 12(7):668. PubMed ID: 34215720
[TBL] [Abstract][Full Text] [Related]
29. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
30. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
31. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
33. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
[TBL] [Abstract][Full Text] [Related]
34. Differential expression and function of AR isoforms in prostate cancer.
Zeng R; Liu Z; Sun Y; Xu C
Oncol Rep; 2012 Feb; 27(2):492-8. PubMed ID: 22020793
[TBL] [Abstract][Full Text] [Related]
35. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
Bonaccorsi L; Carloni V; Muratori M; Formigli L; Zecchi S; Forti G; Baldi E
Int J Cancer; 2004 Oct; 112(1):78-86. PubMed ID: 15305378
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.
Morelli MB; Amantini C; Nabissi M; Liberati S; Cardinali C; Farfariello V; Tomassoni D; Quaglia W; Piergentili A; Bonifazi A; Del Bello F; Santoni M; Mammana G; Servi L; Filosa A; Gismondi A; Santoni G
BMC Cancer; 2014 Dec; 14():921. PubMed ID: 25481381
[TBL] [Abstract][Full Text] [Related]
38. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
Meerson A; Yehuda H
BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
[TBL] [Abstract][Full Text] [Related]
39. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
40. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.
Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y
Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
